Clinical Trial Update: CR-CHOP+X in Previously Untreated DEL [Phase 2]

View source ↗

Summary

Phase 2 trial investigating CR-CHOP+X in patients with previously untreated diffuse large B-cell lymphoma (DEL), currently RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CR-CHOP+X

Snippet

Sponsor: Ruijin Hospital | Conditions: DLBCL | Phase 2 | Status: RECRUITING